Enlarged vestibular aqueduct in pediatric sensorineural hearing loss.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19328346.
- Also identified by DOI 10.1016/j.otohns.2008.12.035 and PMC identifier 2846828.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Comparison of the Cincinnati criteria (midpoint >0.9 mm or operculum >1.9 mm) to the Valvassori criterion (midpoint > or =1.5 mm) for enlarged vestibular aqueduct (EVA) in pediatric cochlear implant patients. Cohort study. One hundred thirty pediatric cochlear implant recipients. We reviewed temporal bone CT scans to measure the vestibular aqueduct midpoint and opercular width. The Cincinnati criteria identified 44 percent of patients with EVA versus 16 percent with the Valvassori criterion (P < 0.01). Of those with EVA, 45 percent were unilateral and 55 percent were bilateral using Cincinnati criteria; 64 percent were unilateral and 36 percent bilateral using Valvassori criterion (P < 0.01). The Cincinnati criteria diagnosed 70 ears with EVA classified as normal using the Valvassori criterion (P < 0.01); 59 lacked another medical explanation for their hearing loss. The Cincinnati criteria identified a large percentage of pediatric cochlear implant patients with EVA who might otherwise have no known etiology for their deafness.
Medical subject headings
- Hearing Loss, Sensorineural
- Vestibular Aqueduct